Share Price and Basic Stock Data
Last Updated: December 5, 2025, 4:52 am
| PEG Ratio | 0.45 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alufluoride Ltd operates in the chemicals sector, specifically focusing on inorganic chemicals. The company’s recent price stood at ₹420, with a market capitalization of ₹328 Cr. Notably, its revenue from operations has shown a significant upward trajectory, rising from ₹88 Cr in FY 2022 to ₹136 Cr in FY 2023, and projected at ₹165 Cr for FY 2024. The quarterly sales figures also reflect this positive trend, recording ₹44.63 Cr in September 2023, up from ₹36.84 Cr in March 2023. However, the subsequent quarter showed a slight decline to ₹37.64 Cr in December 2023, indicating some volatility. The company reported total sales of ₹199 Cr in the trailing twelve months (TTM), which illustrates consistent growth in the overall revenue stream. This growth can be attributed to increased demand for their products and effective operational strategies, positioning Alufluoride favorably within the sector.
Profitability and Efficiency Metrics
Alufluoride’s profitability metrics reflect a robust operational performance, with a reported operating profit margin (OPM) of 16.57%. For FY 2023, the operating profit stood at ₹27 Cr, rising to ₹34 Cr in FY 2024, indicating effective cost management strategies. The net profit for the same periods reported an increase from ₹14 Cr in FY 2023 to ₹18 Cr in FY 2024, maintaining a net profit margin of 9.59% in FY 2025. The return on equity (ROE) stood at an impressive 20.8%, while return on capital employed (ROCE) was recorded at 23.6%. These figures highlight the company’s efficiency in generating profits relative to shareholder equity and capital employed. Moreover, the interest coverage ratio (ICR) of 14.44x suggests that the company is well-positioned to handle its interest obligations, enhancing its financial resilience.
Balance Sheet Strength and Financial Ratios
Alufluoride’s balance sheet exhibits significant strength, with total assets reported at ₹149 Cr for FY 2025, an increase from ₹115 Cr in FY 2023. The company holds reserves of ₹105 Cr, providing a solid cushion against potential downturns. Total borrowings were reported at ₹32 Cr, reflecting a manageable debt level, especially in light of the company’s equity capital of ₹8 Cr. The total debt-to-equity ratio stood at 0.22, indicating a conservative leverage position compared to industry norms. The current ratio of 5.05x suggests excellent liquidity, enabling the company to easily cover short-term obligations. Furthermore, the book value per share rose significantly from ₹71.06 in FY 2022 to ₹130.15 in FY 2025, reinforcing the company’s financial stability and growth potential.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alufluoride Ltd reveals a strong promoter backing, with promoters holding 59.93% of the equity as of March 2025. This stability is complemented by a minimal foreign institutional investor (FII) presence at 0.05% and domestic institutional investors (DII) holding 1.28%. The public holds 38.74%, indicating a healthy distribution of shares among retail investors. The number of shareholders has increased from 12,140 in March 2023 to 15,670 by September 2025, suggesting growing investor confidence in the company’s prospects. The consistent promoter holding combined with an increasing shareholder base reflects positively on the company’s governance and future potential, which is likely to foster further interest from institutional investors.
Outlook, Risks, and Final Insight
Looking ahead, Alufluoride’s growth trajectory appears promising, supported by strong financials and operational efficiency. However, risks such as potential volatility in raw material prices and market demand fluctuations could pose challenges. Additionally, the company’s minimal foreign institutional investment may limit access to larger pools of capital for expansion. Despite these risks, Alufluoride’s strong balance sheet and high ROE suggest resilience and potential for sustained profitability. If the company can successfully mitigate these risks, particularly through efficient supply chain management and maintaining product quality, it may continue to attract investor interest and achieve further growth. Conversely, failure to address these challenges could hinder its ability to capitalize on market opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alufluoride Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 3,040 Cr. | 46.9 | 125/40.8 | 151 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.5 Cr. | 29.0 | 47.2/25.8 | 63.2 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 201 Cr. | 257 | 410/238 | 12.0 | 211 | 3.12 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,254 Cr. | 507 | 728/408 | 30.5 | 157 | 0.59 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 332 Cr. | 425 | 536/376 | 16.2 | 144 | 0.71 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,704.38 Cr | 575.81 | 186.84 | 160.00 | 0.51% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 26.91 | 35.86 | 38.01 | 36.84 | 36.73 | 44.63 | 37.64 | 45.71 | 33.71 | 53.20 | 47.60 | 54.01 | 43.76 |
| Expenses | 22.44 | 29.40 | 28.64 | 28.73 | 28.73 | 33.95 | 30.73 | 37.07 | 26.07 | 42.62 | 36.75 | 46.44 | 36.51 |
| Operating Profit | 4.47 | 6.46 | 9.37 | 8.11 | 8.00 | 10.68 | 6.91 | 8.64 | 7.64 | 10.58 | 10.85 | 7.57 | 7.25 |
| OPM % | 16.61% | 18.01% | 24.65% | 22.01% | 21.78% | 23.93% | 18.36% | 18.90% | 22.66% | 19.89% | 22.79% | 14.02% | 16.57% |
| Other Income | 0.24 | 0.21 | 0.33 | 0.37 | 0.24 | 0.53 | 0.38 | 0.91 | 0.65 | 0.43 | 0.13 | -2.02 | 0.34 |
| Interest | 0.65 | 0.65 | 0.82 | 0.77 | 0.82 | 0.81 | 0.77 | 0.73 | 0.69 | 0.52 | 0.62 | 0.64 | 0.77 |
| Depreciation | 1.66 | 1.73 | 2.07 | 1.96 | 2.09 | 2.16 | 2.18 | 2.19 | 2.19 | 2.27 | 2.26 | 2.25 | 2.29 |
| Profit before tax | 2.40 | 4.29 | 6.81 | 5.75 | 5.33 | 8.24 | 4.34 | 6.63 | 5.41 | 8.22 | 8.10 | 2.66 | 4.53 |
| Tax % | 27.92% | 22.84% | 31.57% | 27.48% | 31.89% | 27.55% | 29.95% | 17.19% | 28.28% | 18.98% | 24.94% | 39.47% | 29.80% |
| Net Profit | 1.74 | 3.32 | 4.66 | 4.17 | 3.64 | 5.98 | 3.04 | 5.49 | 3.88 | 6.66 | 6.08 | 1.60 | 3.18 |
| EPS in Rs | 2.22 | 4.25 | 5.96 | 5.33 | 4.65 | 7.65 | 3.89 | 7.02 | 4.96 | 8.52 | 7.77 | 2.05 | 4.07 |
Last Updated: August 20, 2025, 12:00 am
Below is a detailed analysis of the quarterly data for Alufluoride Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 43.76 Cr.. The value appears to be declining and may need further review. It has decreased from 54.01 Cr. (Mar 2025) to 43.76 Cr., marking a decrease of 10.25 Cr..
- For Expenses, as of Jun 2025, the value is 36.51 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 46.44 Cr. (Mar 2025) to 36.51 Cr., marking a decrease of 9.93 Cr..
- For Operating Profit, as of Jun 2025, the value is 7.25 Cr.. The value appears to be declining and may need further review. It has decreased from 7.57 Cr. (Mar 2025) to 7.25 Cr., marking a decrease of 0.32 Cr..
- For OPM %, as of Jun 2025, the value is 16.57%. The value appears strong and on an upward trend. It has increased from 14.02% (Mar 2025) to 16.57%, marking an increase of 2.55%.
- For Other Income, as of Jun 2025, the value is 0.34 Cr.. The value appears strong and on an upward trend. It has increased from -2.02 Cr. (Mar 2025) to 0.34 Cr., marking an increase of 2.36 Cr..
- For Interest, as of Jun 2025, the value is 0.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.64 Cr. (Mar 2025) to 0.77 Cr., marking an increase of 0.13 Cr..
- For Depreciation, as of Jun 2025, the value is 2.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.25 Cr. (Mar 2025) to 2.29 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.53 Cr.. The value appears strong and on an upward trend. It has increased from 2.66 Cr. (Mar 2025) to 4.53 Cr., marking an increase of 1.87 Cr..
- For Tax %, as of Jun 2025, the value is 29.80%. The value appears to be improving (decreasing) as expected. It has decreased from 39.47% (Mar 2025) to 29.80%, marking a decrease of 9.67%.
- For Net Profit, as of Jun 2025, the value is 3.18 Cr.. The value appears strong and on an upward trend. It has increased from 1.60 Cr. (Mar 2025) to 3.18 Cr., marking an increase of 1.58 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.07. The value appears strong and on an upward trend. It has increased from 2.05 (Mar 2025) to 4.07, marking an increase of 2.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29 | 22 | 31 | 36 | 50 | 66 | 76 | 38 | 88 | 136 | 165 | 189 | 199 |
| Expenses | 28 | 19 | 27 | 34 | 41 | 56 | 60 | 37 | 74 | 109 | 130 | 152 | 162 |
| Operating Profit | 1 | 2 | 3 | 3 | 9 | 10 | 16 | 2 | 14 | 27 | 34 | 36 | 36 |
| OPM % | 4% | 11% | 10% | 7% | 18% | 15% | 21% | 4% | 16% | 20% | 21% | 19% | 18% |
| Other Income | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | -1 | -1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 3 | 2 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 6 | 7 | 9 | 9 | 9 |
| Profit before tax | 1 | 4 | 3 | 5 | 9 | 11 | 15 | -1 | 5 | 19 | 25 | 24 | 24 |
| Tax % | 34% | 15% | 37% | 25% | 29% | 24% | 29% | -48% | 27% | 28% | 26% | 25% | |
| Net Profit | 1 | 3 | 2 | 3 | 6 | 8 | 10 | -1 | 4 | 14 | 18 | 18 | 18 |
| EPS in Rs | 1.39 | 4.34 | 3.09 | 4.93 | 9.23 | 11.80 | 13.22 | -0.70 | 4.87 | 17.75 | 23.20 | 23.41 | 22.41 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 15% | 0% | 21% | 11% | 13% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | -33.33% | 50.00% | 100.00% | 33.33% | 25.00% | -110.00% | 500.00% | 250.00% | 28.57% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -233.33% | 83.33% | 50.00% | -66.67% | -8.33% | -135.00% | 610.00% | -250.00% | -221.43% | -28.57% |
Alufluoride Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 20% |
| 3 Years: | 29% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 14% |
| 3 Years: | 73% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 15% |
| 3 Years: | 19% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 16% |
| 3 Years: | 22% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 8 | 10 | 12 | 17 | 26 | 33 | 45 | 44 | 48 | 62 | 79 | 95 | 105 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 32 | 30 | 31 | 24 | 30 | 32 |
| Other Liabilities | 4 | 6 | 5 | 7 | 7 | 9 | 13 | 12 | 14 | 15 | 18 | 16 | 20 |
| Total Liabilities | 20 | 23 | 25 | 31 | 40 | 49 | 80 | 95 | 100 | 115 | 128 | 149 | 165 |
| Fixed Assets | 4 | 3 | 2 | 3 | 5 | 14 | 21 | 26 | 56 | 64 | 63 | 64 | 65 |
| CWIP | 0 | 0 | 0 | 0 | 2 | 4 | 34 | 34 | 2 | 2 | 1 | 5 | 5 |
| Investments | 5 | 5 | 6 | 13 | 17 | 13 | 1 | 6 | 9 | 12 | 26 | 31 | 41 |
| Other Assets | 10 | 15 | 16 | 15 | 15 | 19 | 23 | 29 | 33 | 37 | 39 | 50 | 53 |
| Total Assets | 20 | 23 | 25 | 31 | 40 | 49 | 80 | 95 | 100 | 115 | 128 | 149 | 165 |
Below is a detailed analysis of the balance sheet data for Alufluoride Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 30.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 149.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Investments, as of Sep 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 3.00 Cr..
- For Total Assets, as of Sep 2025, the value is 165.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 165.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (105.00 Cr.) exceed the Borrowings (32.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 2.00 | 3.00 | 3.00 | 9.00 | 10.00 | 1.00 | -30.00 | -16.00 | -4.00 | 10.00 | 6.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 32 | 25 | 43 | 40 | 30 | 32 | 15 | 48 | 56 | 37 | 28 | 38 |
| Inventory Days | 50 | 288 | 126 | 74 | 63 | 39 | 47 | 66 | 79 | 66 | 37 | 56 |
| Days Payable | 39 | 111 | 42 | 49 | 39 | 29 | 25 | 38 | 39 | 21 | 28 | 19 |
| Cash Conversion Cycle | 43 | 202 | 128 | 65 | 54 | 42 | 37 | 76 | 96 | 82 | 37 | 76 |
| Working Capital Days | 46 | 98 | 87 | 53 | 34 | 30 | -8 | 35 | 46 | 37 | 15 | 53 |
| ROCE % | 10% | 22% | 19% | 15% | 32% | 27% | 28% | -0% | 9% | 24% | 25% | 24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.13 | 22.59 | 16.39 | 4.50 | -0.70 |
| Diluted EPS (Rs.) | 23.13 | 22.59 | 16.39 | 4.50 | -0.70 |
| Cash EPS (Rs.) | 34.60 | 33.43 | 25.45 | 12.62 | 2.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 130.15 | 108.96 | 87.00 | 71.06 | 66.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 130.15 | 108.96 | 87.00 | 71.06 | 66.33 |
| Revenue From Operations / Share (Rs.) | 241.06 | 207.03 | 174.04 | 112.47 | 49.22 |
| PBDIT / Share (Rs.) | 45.51 | 45.64 | 36.03 | 17.91 | 3.02 |
| PBIT / Share (Rs.) | 34.04 | 34.60 | 26.55 | 9.79 | -0.18 |
| PBT / Share (Rs.) | 30.89 | 30.57 | 22.84 | 6.34 | -1.36 |
| Net Profit / Share (Rs.) | 23.13 | 22.40 | 15.97 | 4.50 | -0.70 |
| NP After MI And SOA / Share (Rs.) | 23.13 | 22.59 | 16.39 | 4.50 | -0.70 |
| PBDIT Margin (%) | 18.88 | 22.04 | 20.70 | 15.92 | 6.13 |
| PBIT Margin (%) | 14.12 | 16.71 | 15.25 | 8.70 | -0.37 |
| PBT Margin (%) | 12.81 | 14.76 | 13.12 | 5.63 | -2.76 |
| Net Profit Margin (%) | 9.59 | 10.81 | 9.17 | 4.00 | -1.42 |
| NP After MI And SOA Margin (%) | 9.59 | 10.90 | 9.41 | 4.00 | -1.42 |
| Return on Networth / Equity (%) | 17.77 | 20.89 | 18.85 | 6.33 | -1.06 |
| Return on Capital Employeed (%) | 19.98 | 25.47 | 21.77 | 9.31 | -0.17 |
| Return On Assets (%) | 12.20 | 13.76 | 11.23 | 3.52 | -0.57 |
| Long Term Debt / Equity (X) | 0.19 | 0.09 | 0.21 | 0.28 | 0.38 |
| Total Debt / Equity (X) | 0.22 | 0.19 | 0.34 | 0.40 | 0.46 |
| Asset Turnover Ratio (%) | 1.36 | 1.34 | 1.26 | 0.89 | 0.00 |
| Current Ratio (X) | 5.05 | 2.66 | 2.41 | 1.85 | 1.92 |
| Quick Ratio (X) | 3.78 | 2.18 | 1.56 | 1.13 | 1.39 |
| Inventory Turnover Ratio (X) | 8.60 | 7.53 | 6.44 | 6.28 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 8.85 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 5.94 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 91.15 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 94.06 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 14.44 | 11.33 | 9.70 | 5.18 | 2.57 |
| Interest Coverage Ratio (Post Tax) (X) | 8.34 | 6.56 | 5.30 | 2.30 | 0.40 |
| Enterprise Value (Cr.) | 379.89 | 373.36 | 255.20 | 256.35 | 189.40 |
| EV / Net Operating Revenue (X) | 2.02 | 2.31 | 1.87 | 2.91 | 4.92 |
| EV / EBITDA (X) | 10.67 | 10.46 | 9.06 | 18.30 | 80.16 |
| MarketCap / Net Operating Revenue (X) | 1.92 | 2.25 | 1.72 | 2.68 | 4.51 |
| Retention Ratios (%) | 0.00 | 91.14 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.56 | 4.32 | 3.45 | 4.24 | 3.35 |
| Price / Net Operating Revenue (X) | 1.92 | 2.25 | 1.72 | 2.68 | 4.51 |
| EarningsYield | 0.04 | 0.04 | 0.05 | 0.01 | 0.00 |
After reviewing the key financial ratios for Alufluoride Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.60. This value is within the healthy range. It has increased from 33.43 (Mar 24) to 34.60, marking an increase of 1.17.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 130.15. It has increased from 108.96 (Mar 24) to 130.15, marking an increase of 21.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 130.15. It has increased from 108.96 (Mar 24) to 130.15, marking an increase of 21.19.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 241.06. It has increased from 207.03 (Mar 24) to 241.06, marking an increase of 34.03.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 45.51. This value is within the healthy range. It has decreased from 45.64 (Mar 24) to 45.51, marking a decrease of 0.13.
- For PBIT / Share (Rs.), as of Mar 25, the value is 34.04. This value is within the healthy range. It has decreased from 34.60 (Mar 24) to 34.04, marking a decrease of 0.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 30.89. This value is within the healthy range. It has increased from 30.57 (Mar 24) to 30.89, marking an increase of 0.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 23.13, marking an increase of 0.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.13. This value is within the healthy range. It has increased from 22.59 (Mar 24) to 23.13, marking an increase of 0.54.
- For PBDIT Margin (%), as of Mar 25, the value is 18.88. This value is within the healthy range. It has decreased from 22.04 (Mar 24) to 18.88, marking a decrease of 3.16.
- For PBIT Margin (%), as of Mar 25, the value is 14.12. This value is within the healthy range. It has decreased from 16.71 (Mar 24) to 14.12, marking a decrease of 2.59.
- For PBT Margin (%), as of Mar 25, the value is 12.81. This value is within the healthy range. It has decreased from 14.76 (Mar 24) to 12.81, marking a decrease of 1.95.
- For Net Profit Margin (%), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 9.59, marking a decrease of 1.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.59. This value is within the healthy range. It has decreased from 10.90 (Mar 24) to 9.59, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.77. This value is within the healthy range. It has decreased from 20.89 (Mar 24) to 17.77, marking a decrease of 3.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.98. This value is within the healthy range. It has decreased from 25.47 (Mar 24) to 19.98, marking a decrease of 5.49.
- For Return On Assets (%), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 13.76 (Mar 24) to 12.20, marking a decrease of 1.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has increased from 0.09 (Mar 24) to 0.19, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.22, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.36. It has increased from 1.34 (Mar 24) to 1.36, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 5.05. This value exceeds the healthy maximum of 3. It has increased from 2.66 (Mar 24) to 5.05, marking an increase of 2.39.
- For Quick Ratio (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 2. It has increased from 2.18 (Mar 24) to 3.78, marking an increase of 1.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.60. This value exceeds the healthy maximum of 8. It has increased from 7.53 (Mar 24) to 8.60, marking an increase of 1.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.85 (Mar 24) to 0.00, marking a decrease of 8.85.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.94 (Mar 24) to 0.00, marking a decrease of 5.94.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.15 (Mar 24) to 0.00, marking a decrease of 91.15.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.06 (Mar 24) to 0.00, marking a decrease of 94.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.44. This value is within the healthy range. It has increased from 11.33 (Mar 24) to 14.44, marking an increase of 3.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.34. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 8.34, marking an increase of 1.78.
- For Enterprise Value (Cr.), as of Mar 25, the value is 379.89. It has increased from 373.36 (Mar 24) to 379.89, marking an increase of 6.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 2.02, marking a decrease of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 10.67. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 10.67, marking an increase of 0.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.92, marking a decrease of 0.33.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.14 (Mar 24) to 0.00, marking a decrease of 91.14.
- For Price / BV (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has decreased from 4.32 (Mar 24) to 3.56, marking a decrease of 0.76.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.92, marking a decrease of 0.33.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alufluoride Ltd:
- Net Profit Margin: 9.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.98% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.77% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.78
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.2 (Industry average Stock P/E: 169.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.59%
About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Mulagada, Mindi, Vishakapatnam Andhra Pradesh 530012 | contact@alufluoride.com http://www.alufluoride.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Grandhi Sreeramakrishna | Chairman & Ind.Dire (Non-Exe) |
| Mr. Venkat Akkineni | Managing Director |
| Mrs. Jyothsana Akkineni | Executive Director |
| Mr. K Purushotham Naidu | Director |
| Mr. Ashok Vemulapalli | Non Exe.Non Ind.Director |
| Mr. A V V S S Ch B Sekhar Babu | Ind. Non-Executive Director |
| Mr. Yugandhar Meka | Ind. Non-Executive Director |
Alufluoride Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹485.00 |
| Previous Day | ₹489.20 |
FAQ
What is the intrinsic value of Alufluoride Ltd?
Alufluoride Ltd's intrinsic value (as of 05 December 2025) is 390.93 which is 8.02% lower the current market price of 425.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 332 Cr. market cap, FY2025-2026 high/low of 536/376, reserves of ₹105 Cr, and liabilities of 165 Cr.
What is the Market Cap of Alufluoride Ltd?
The Market Cap of Alufluoride Ltd is 332 Cr..
What is the current Stock Price of Alufluoride Ltd as on 05 December 2025?
The current stock price of Alufluoride Ltd as on 05 December 2025 is 425.
What is the High / Low of Alufluoride Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alufluoride Ltd stocks is 536/376.
What is the Stock P/E of Alufluoride Ltd?
The Stock P/E of Alufluoride Ltd is 16.2.
What is the Book Value of Alufluoride Ltd?
The Book Value of Alufluoride Ltd is 144.
What is the Dividend Yield of Alufluoride Ltd?
The Dividend Yield of Alufluoride Ltd is 0.71 %.
What is the ROCE of Alufluoride Ltd?
The ROCE of Alufluoride Ltd is 23.6 %.
What is the ROE of Alufluoride Ltd?
The ROE of Alufluoride Ltd is 20.8 %.
What is the Face Value of Alufluoride Ltd?
The Face Value of Alufluoride Ltd is 10.0.